Western blotting showed that MCT4 protein expression was essentially ablated 48 h after transfection of MDA-MB-231 human breast cancer cells with siRNA targeting MCT4 (Fig. 1A,Bi). This evidence concerns the gene SLC16A3 and breast carcinoma.